JPMorgan Chase & Co’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Sell |
304,321
-14,622
| -5% | -$519K | ﹤0.01% | 2157 |
|
|
2025
Q1 | $10.8M | Sell |
318,943
-679,073
| -68% | -$23M | ﹤0.01% | 2131 |
|
|
2024
Q4 | $32.5M | Buy |
998,016
+634,990
| +175% | +$20.7M | ﹤0.01% | 1395 |
|
|
2024
Q3 | $17.7M | Buy |
363,026
+7,078
| +2% | +$345K | ﹤0.01% | 1787 |
|
|
2024
Q2 | $15.8M | Sell |
355,948
-41,251
| -10% | -$1.83M | ﹤0.01% | 1799 |
|
|
2024
Q1 | $22.3M | Sell |
397,199
-91,927
| -19% | -$5.16M | ﹤0.01% | 1617 |
|
|
2023
Q4 | $29.4M | Buy |
489,126
+37,301
| +8% | +$2.24M | ﹤0.01% | 1375 |
|
|
2023
Q3 | $30.3M | Sell |
451,825
-123,417
| -21% | -$8.29M | ﹤0.01% | 1251 |
|
|
2023
Q2 | $39.7M | Buy |
575,242
+19,226
| +3% | +$1.33M | ﹤0.01% | 1124 |
|
|
2023
Q1 | $26.8M | Buy |
556,016
+83,615
| +18% | +$4.03M | ﹤0.01% | 1294 |
|
|
2022
Q4 | $23.6M | Sell |
472,401
-42,333
| -8% | -$2.11M | ﹤0.01% | 1324 |
|
|
2022
Q3 | $21M | Buy |
514,734
+38,354
| +8% | +$1.56M | ﹤0.01% | 1365 |
|
|
2022
Q2 | $26.2M | Buy |
476,380
+70,979
| +18% | +$3.9M | ﹤0.01% | 1258 |
|
|
2022
Q1 | $14.7M | Buy |
405,401
+157,330
| +63% | +$5.72M | ﹤0.01% | 1760 |
|
|
2021
Q4 | $11.6M | Buy |
248,071
+150,159
| +153% | +$7M | ﹤0.01% | 1982 |
|
|
2021
Q3 | $4.95M | Buy |
97,912
+26,103
| +36% | +$1.32M | ﹤0.01% | 2585 |
|
|
2021
Q2 | $2.95M | Buy |
71,809
+6,727
| +10% | +$276K | ﹤0.01% | 2986 |
|
|
2021
Q1 | $1.89M | Buy |
65,082
+24,519
| +60% | +$711K | ﹤0.01% | 3276 |
|
|
2020
Q4 | $1.14M | Buy |
40,563
+2,916
| +8% | +$82.1K | ﹤0.01% | 3295 |
|
|
2020
Q3 | $1.16M | Buy |
37,647
+32,647
| +653% | +$1.01M | ﹤0.01% | 3024 |
|
|
2020
Q2 | $213K | Buy |
+5,000
| New | +$213K | ﹤0.01% | 3637 |
|